Physician profile
Wasif A Qureshi
NPI 1861619975
$121,910.28
in general payments reported to CMS, 2019-2025
43 companies · $86K in 2025
The $86K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $4,226 · 2021: $841 · 2022: $5,393 · 2023: $13K · 2024: $1,306 · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $66K · Consulting Fee: $18K · Travel and Lodging: $8,987 · Food and Beverage: $7,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $65,573.44 |
| Consulting Fee | $18,297.50 |
| Travel and Lodging | $8,986.76 |
| Food and Beverage | $7,329.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $77,612.22 | 2023-2025 | Ozempic, Wegovy |
| Boston Scientific Corporation | $21,072.01 | 2019-2024 | Watchman Access System, Watchman Flx, Bodyguardian |
| Abbott Laboratories | $15,940.50 | 2019-2025 | Amplatzer Amulet, Mitraclip, Triclip |
| Edwards Lifesciences Corporation | $1,493.42 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Amgen INC. | $732.35 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals Lp | $524.69 | 2019-2024 | Brilinta |
| Novartis Pharmaceuticals Corporation | $493.08 | 2019-2024 | |
| Medtronic, INC. | $416.87 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Mycarelink |
| Pfizer INC. | $315.71 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $295.40 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $285.39 | 2019-2025 | Lifevest |
| Heartflow, INC. | $268.79 | 2023-2024 | Ffrct |
| Medtronic Vascular, INC. | $261.78 | 2019-2020 | |
| Esperion Therapeutics, INC. | $226.26 | 2020-2024 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $220.45 | 2019-2025 | Jardiance |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $204.07 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $151.68 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $149.68 | 2021-2023 | Verquvo |
| Canon Medical Systems USA, INC. | $139.37 | 2025 | Ct Scanner |
| Regeneron Healthcare Solutions, INC. | $108.90 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $98.30 | 2019-2025 | |
| Celonova Biosciences, INC. | $96.11 | 2019 | |
| Abiomed | $94.58 | 2023 | Impella |
| Cardiva Medical, INC. | $88.37 | 2020-2024 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f |
| Amarin Pharma, INC. | $87.66 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $73.81 | 2023-2024 | Inpefa |
| Brainsway USA INC | $50.23 | 2025 | |
| Chiesi USA, INC. | $45.56 | 2019 | |
| Biotronik INC. | $45.14 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $44.09 | 2019 | |
| Scpharmaceuticals INC. | $41.10 | 2024 | |
| Janssen Scientific Affairs, LLC | $34.96 | 2023 | Xarelto |
| Philips North America LLC | $28.41 | 2020 | |
| Shockwave Medical, INC | $27.44 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.89 | 2025 | |
| W. L. Gore & Associates, INC. | $20.22 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Arbor Pharmaceuticals, INC. | $16.61 | 2019 | |
| Surmodics, INC. | $16.39 | 2024 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Bridgebio Pharma, INC. | $15.70 | 2025 | Attruby |
| Agepha Pharma Fz LLC | $15.10 | 2025 | Lodoco |
| Kiniksa Pharmaceuticals, Ltd. | $14.26 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $13.97 | 2024 | Arcalyst |
| Acarix USA INC. | $8.76 | 2023 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wasif Qureshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.